Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Adams Respiratory Therapeutics
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Ages Eligible for Study: 18 to 75 years,
Genders Eligible for Study: Both
Adult patients presenting at the physician's office with symptoms diagnostic for acute respiratory infection, such as bronchitis or rhinosinusitis; with a clinical diagnosis of acute respiratory infection, meeting the physician's usual diagnostic criteria in practice for prescription of oral antibiotics.
The investigator will evaluate patients on a total of seven criteria for inclusion.
You may not be if
Have chronic, recurring respiratory signs and symptoms, such as allergic rhinitis or chronic bronchitis, which, in the investigator's opinion, would confound interpretation of symptoms ratings for the acute respiratory infection;
The Investigator will evaluate patients on twelve additional criteria for exclusion.
Clareo Health | Phase 4 Study - Mucinex D as Adjunct Therapy
